SHEL.UK

2,786.5

+1.22%↑

BP

454

+1.62%↑

SHEL.UK

2,786.5

+1.22%↑

BP

454

+1.62%↑

SHEL.UK

2,786.5

+1.22%↑

BP

454

+1.62%↑

SHEL.UK

2,786.5

+1.22%↑

BP

454

+1.62%↑

SHEL.UK

2,786.5

+1.22%↑

BP

454

+1.62%↑

Search

Smith & Nephew PLC

Lezárt

1,258 -0.12

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

1255

Maximum

1260

Fő mutatók

By Trading Economics

Bevétel

296M

Értékesítés

3B

P/E

Szektor átlag

29.209

21.782

Egy részvényre jutó nyereség

0.429

Osztalékhozam

3.05

Profit margin

9.895

Munkavállalók

17,000

EBITDA

723M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+16.73% upside

Osztalékok

By Dow Jones

Osztalékhozam

Szektor átlag

3.05%

4.37%

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

1.7B

11B

Előző nyitás

1258.12

Előző zárás

1258

Smith & Nephew PLC Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2025. nov. 28. 15:29 UTC

Fő piaci mozgatók
Felvásárlások, összeolvadások, átvételek

China's Jiangxi Copper Rejected by SolGold in $1 Billion Takeover Approach

2025. nov. 28. 21:50 UTC

Piaci beszéd

Auto & Transport Roundup: Market Talk

2025. nov. 28. 19:59 UTC

Piaci beszéd

Oil Futures Settle Lower in Slow Black Friday Trade -- Market Talk

2025. nov. 28. 19:47 UTC

Piaci beszéd

U.S. Natural Gas Lifted By Cold Weather Outlook -- Market Talk

2025. nov. 28. 18:16 UTC

Piaci beszéd

Global Equities Roundup: Market Talk

2025. nov. 28. 18:16 UTC

Piaci beszéd

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

2025. nov. 28. 18:08 UTC

Piaci beszéd

Market Talk Roundup: Latest on U.S. Politics

2025. nov. 28. 18:08 UTC

Piaci beszéd

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

2025. nov. 28. 17:48 UTC

Piaci beszéd

Bank of Canada May Revise Up Inflation Projections After GDP Data -- Market Talk

2025. nov. 28. 17:20 UTC

Piaci beszéd

Auto & Transport Roundup: Market Talk

2025. nov. 28. 16:50 UTC

Felvásárlások, összeolvadások, átvételek

Week's Best: Sieg's Stature at Citi Grows -- Barrons.com

2025. nov. 28. 15:51 UTC

Piaci beszéd

Canada Household Spending Edges Lower -- Market Talk

2025. nov. 28. 15:33 UTC

Piaci beszéd

Crude Futures Gain as U.S. Market Reopens -- Market Talk

2025. nov. 28. 15:21 UTC

Piaci beszéd

Gold Rises on U.S. Rate-Cut Bets After CME Outage -- Market Talk

2025. nov. 28. 15:13 UTC

Piaci beszéd

Dollar Recovers Slightly as Investors Already Price in Fed Rate Cut -- Market Talk

2025. nov. 28. 15:11 UTC

Piaci beszéd

Global Equities Roundup: Market Talk

2025. nov. 28. 15:11 UTC

Piaci beszéd

Canadian National Railway Showing Positive Trend Going Into 2026 -- Market Talk

2025. nov. 28. 14:51 UTC

Piaci beszéd

Canada GDP Report Masks Fragile State of Economy -- Market Talk

2025. nov. 28. 14:41 UTC

Piaci beszéd

Canada's GDP Level Pulled Higher by 'Eye-Opening' Revisions -- Market Talk

2025. nov. 28. 14:37 UTC

Piaci beszéd

U.S. Natural Gas Futures Rise As Temperatures Drop -- Market Talk

2025. nov. 28. 14:33 UTC

Piaci beszéd

Global Forex and Fixed Income Roundup: Market Talk

2025. nov. 28. 14:33 UTC

Piaci beszéd

Steep Import Drop Fuels Surprise Lift in Canada GDP -- Market Talk

2025. nov. 28. 14:20 UTC

Piaci beszéd

Too Much Noise in Canada's Surprise 3Q GDP Gain -- Market Talk

2025. nov. 28. 14:10 UTC

Piaci beszéd

Canadian Nowcast Came Closest to Predicting Surprise 3Q Strength -- Market Talk

2025. nov. 28. 13:39 UTC

Piaci beszéd

Global Forex and Fixed Income Roundup: Market Talk

2025. nov. 28. 13:39 UTC

Piaci beszéd

Canada Trade Data Could Face Larger-Than-Normal Revisions -- Market Talk

2025. nov. 28. 13:36 UTC

Piaci beszéd

Canada's Economy Expands More Than Expected -- Market Talk

2025. nov. 28. 13:29 UTC

Piaci beszéd

CME Outage Sowing Chaos Across Markets, Trade Nations Says -- Market Talk

2025. nov. 28. 13:27 UTC

Piaci beszéd

Russia-Ukraine Peace Efforts to Have Little Impact on Oil Fundamentals -- Market Talk

2025. nov. 28. 13:19 UTC

Piaci beszéd

Global Forex and Fixed Income Roundup: Market Talk

Társak összehasonlítása

Árváltozás

Smith & Nephew PLC Előrejelzés

Célár

By TipRanks

16.73% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 1,464.44 GBX  16.73%

Magas 1,700 GBX

Alacsony 1,014.979 GBX

9 Wall Street elemző 12 hónapos célárain alapulva a(z)Smith & Nephew PLC termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

9 ratings

6

Vétel

3

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat